Irloxacin

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

伊洛沙星是一种新的喹诺酮衍生物，在酸性 pH 条件下表现出更高的活性。伊洛沙星对革兰氏阳性菌和革兰氏阴性菌均具有良好的体外抗菌谱。

Irloxacin is a new quinolone derivative, and shows greater activity with an acid pH. Irloxacin has a good in vitro antimicrobial spectrum against both gram-positive and gram-negative bacteria.(In Vitro):We have compared the in vitro activity of irloxacin against mycobacteria (20 M. tuberculosis, 17 M. avium, 5 Mycobacterium bovis, 5 Mycobacterium chelonae, 5 Mycobacterium fortuitum and 1 Mycobacterium gadium) using the Bactec at pH 6.8 and 5.0, with other quinolones (ofloxacin, ciprofloxacin, pefloxacin and 27753 RP). All quinolones tested showed good activity against mycobacteria at pH 6.8 and 5.0. Irloxacin at pH 5.0 had a greater activity against M. avium.

——

——

Pirfloxacin

GPCR/G Protein

Antibacterial

A2B

——

——

91524-15-1

300.28

C16H13FN2O3

>98% (HPLC)

In Vitro:?DMSO : 33.33 mg/mL (111.00 mM)

CCN(C=C(C(O)=O)C(c1c2)=O)c1cc(-n1cccc1)c2F

——

(-20℃)

With Ice Pack

≥ 2 years